Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    21857944 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
A Crossover Study of the Acute Effects of Olanzapine in Healthy Volunteers
Conditions: Insulin Resistance;   Diabetes Mellitus
Interventions: Drug: Olanzapine 10 mg po qhs for 3 days;   Drug: Placebo

Indicates status has not been verified in more than two years